Semaglutide, a GLP-1 receptor agonist used for weight loss and blood sugar control, undergoes hepatic processing, raising legitimate safety questions for cirrhotic patients
[1] Patients should be counselled to recognise symptoms of both hypoglycaemia (tremor, sweating, confusion, palpitations) and hyperglycaemia (increased thirst, frequent urination, fatigue), and to contact their GP or diabetes specialist nurse if concerns arise
Gradual dose titration offers a practical mitigation strategy
Easy to remove the next day
Subjects applied GSSG 2% (weight/weight [w/w]) lotion to one side of the face and a placebo lotion to the other side twice daily for 10 weeks
Uma vez que a grelina, alm da libertao de GH, tambm promove a motilidade gastrointestinal, o efeito procintico de um mimtico seletivo da grelina biologicamente plausvel e coincide com os dados em roedores de Venkova et al., 2009